Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Free Cash Flow Generation Index
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥344.88 Million represents 1% of operating cash flow (CN¥425.83 Million). Read Jiangsu Nhwa Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Nhwa Pharmaceutical Co Ltd Free Cash Flow Generation Index (2005–2025)
Historical FCF Generation Index trend for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Explore 002262 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year Free Cash Flow Generation Index for Jiangsu Nhwa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Jiangsu Nhwa Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥640.98 Million | CN¥1.08 Billion | CN¥437.41 Million | ▲ +16.8% |
| 2024 | 0.51x | CN¥466.07 Million | CN¥916.13 Million | CN¥450.06 Million | ▼ -19.1% |
| 2023 | 0.63x | CN¥634.31 Million | CN¥1.01 Billion | CN¥373.99 Million | ▲ +1.6% |
| 2022 | 0.62x | CN¥533.27 Million | CN¥861.02 Million | CN¥327.75 Million | ▼ -12.3% |
| 2021 | 0.71x | CN¥495.01 Million | CN¥701.12 Million | CN¥206.11 Million | ▼ -10.0% |
| 2020 | 0.78x | CN¥979.74 Million | CN¥1.25 Billion | CN¥268.61 Million | ▲ +64.8% |
| 2019 | 0.48x | CN¥145.67 Million | CN¥305.97 Million | CN¥160.30 Million | ▼ -17.6% |
| 2018 | 0.58x | CN¥233.83 Million | CN¥404.52 Million | CN¥170.70 Million | ▼ -8.7% |
| 2017 | 0.63x | CN¥286.34 Million | CN¥452.35 Million | CN¥166.01 Million | ▲ +0.3% |
| 2016 | 0.63x | CN¥174.92 Million | CN¥277.14 Million | CN¥102.22 Million | ▲ +1139.9% |
| 2015 | -0.06x | CN¥-12.40 Million | CN¥204.24 Million | CN¥216.63 Million | ▲ +90.4% |
| 2014 | -0.63x | CN¥-101.36 Million | CN¥160.24 Million | CN¥261.60 Million | ▼ -235.5% |
| 2013 | 0.47x | CN¥90.70 Million | CN¥194.33 Million | CN¥103.63 Million | ▼ -5.5% |
| 2012 | 0.49x | CN¥76.16 Million | CN¥154.16 Million | CN¥78.01 Million | ▲ +14.9% |
| 2011 | 0.43x | CN¥34.87 Million | CN¥81.08 Million | CN¥46.21 Million | ▲ +211.8% |
| 2010 | -0.38x | CN¥-23.78 Million | CN¥61.79 Million | CN¥85.57 Million | ▼ -223.3% |
| 2009 | 0.31x | CN¥19.12 Million | CN¥61.27 Million | CN¥42.15 Million | ▲ +59.5% |
| 2008 | 0.20x | CN¥9.10 Million | CN¥46.50 Million | CN¥37.40 Million | ▲ +44.2% |
| 2007 | 0.14x | CN¥6.59 Million | CN¥48.55 Million | CN¥41.96 Million | ▲ +182.4% |
| 2006 | -0.16x | CN¥-5.11 Million | CN¥30.99 Million | CN¥36.09 Million | ▲ +93.7% |
| 2005 | -2.62x | CN¥-23.15 Million | CN¥8.84 Million | CN¥31.99 Million | — |